Revenue from operations also saw strong growth, reaching Rs 9,103.13 crore in Q3FY25, marking a 15.07% year-on-year increase ...
Q4 2024 Management View CEO Tim Herbert highlighted milestones in 2024, including surpassing 90,000 patients treated with Inspire therapy, FDA approval of the Inspire V neurostimulator, and achieving ...